Prospera Private Wealth LLC acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 16,396 shares of the financial services provider's stock, valued at approximately $3,618,000.
A number of other institutional investors have also recently modified their holdings of CME. Wealth Enhancement Advisory Services LLC boosted its stake in CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider's stock valued at $9,477,000 after buying an additional 8,443 shares in the last quarter. Cetera Investment Advisers increased its position in CME Group by 429.1% during the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider's stock worth $10,231,000 after purchasing an additional 38,540 shares in the last quarter. Brookstone Capital Management lifted its stake in CME Group by 12.2% in the 2nd quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider's stock valued at $6,156,000 after purchasing an additional 3,325 shares during the last quarter. Epoch Investment Partners Inc. boosted its position in CME Group by 4.7% in the first quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider's stock valued at $21,518,000 after buying an additional 4,454 shares in the last quarter. Finally, Mather Group LLC. increased its holdings in shares of CME Group by 197.2% during the second quarter. Mather Group LLC. now owns 6,066 shares of the financial services provider's stock worth $1,306,000 after buying an additional 4,025 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.
Insider Activity
In related news, insider Timothy Francis Mccourt sold 1,374 shares of the firm's stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company's stock, valued at $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 over the last three months. Corporate insiders own 0.30% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently weighed in on CME shares. Piper Sandler raised their price objective on CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a report on Monday, October 28th. Redburn Atlantic lowered CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price target on the stock. in a research note on Tuesday, October 8th. Citigroup upped their price objective on CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research note on Thursday, October 24th. Royal Bank of Canada reiterated a "sector perform" rating and set a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $227.00 to $226.00 and set a "hold" rating for the company in a research report on Monday, November 11th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $224.47.
View Our Latest Report on CME
CME Group Stock Down 0.9 %
Shares of CME traded down $2.13 on Wednesday, reaching $227.53. The company's stock had a trading volume of 729,350 shares, compared to its average volume of 1,906,400. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a fifty day moving average of $223.02 and a 200-day moving average of $210.69. The stock has a market capitalization of $81.99 billion, a PE ratio of 24.15, a PEG ratio of 5.20 and a beta of 0.55.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group's quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.25 EPS. Equities analysts predict that CME Group Inc. will post 10.22 EPS for the current year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group's dividend payout ratio is currently 48.37%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.